EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Retrospective Study of the Correlation Between Next-Generation Sequencing and Immunohistochemical Detection of TP53 in Colorectal Cancer

Jingjing Wu iD, Haifeng Yu, Shanshan Huang, Xiangna Chen

Technology in Cancer Research & Treatment · 2026

DOI: 10.1177/15330338261420099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2026. Verfasst von Jingjing Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Suppressor Protein p53, High-Throughput Nucleotide Sequencing, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Fujian Provincial Health and Construction Commission, Young and middle-aged backbone personnel Training Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This retrospective study aimed to investigate the correlation between TP53 identified via next-generation sequencing (NGS) and p53 expression in colorectal adenocarcinoma (CRC), as assessed by immunohistochemistry (IHC). Additionally, we characterized p53 IHC staining patterns and sought to determine the optimal threshold for p53 expression as a surrogate for TP53 mutation status.

Methods

In this retrospective cohort analysis, we included 294 archived surgically resected CRC specimens from patients who did not receive preoperative chemotherapy were analyzed. All data were collected from pathology database and electronic medical records. TP53 mutations were identified using NGS, and p53 expression was evaluated by IHC. The correlation between mutation status and IHC staining patterns was assessed, and sensitivity and specificity were calculated.

Results

The TP53 mutation rate was 78.2%, comprising missense (68.4%), nonsense (12.4%), frameshift (11.0%), and splice-site (8.3%) mutations. Missense mutations were associated with nuclear p53 staining, while frameshift mutations mostly showed loss of expression. Nonsense and splice-site mutations exhibited diverse patterns, including loss of expression, nuclear staining with/without cytoplasmic staining, or cytoplasmic staining alone. Among cases with loss of p53 expression, the TP53 mutation rate was 88.9%. When the proportion of strong p53-positive cells exceeded 55%, the missense mutation-positivity rate increased significantly (P < 0.05). The sensitivity and specificity of p53 IHC in predicting TP53 mutations were 92.3% and 94.8%, respectively.

Conclusions

CRC predominantly exhibited missense TP53 mutations. p53 IHC revealed diverse expression patterns, including overexpression, complete loss, cytoplasmic staining, and normal-type patterns. Strong p53 expression (>55%) correlated closely with TP53 missense mutations, supporting IHC as a reliable surrogate. However, cases showing loss of p53 expression should undergo gene sequencing to confirm mutation status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsTumor Suppressor Protein p53High-Throughput Nucleotide SequencingBiomarkers, TumorHumansImmunohistochemistryFemaleRetrospective StudiesMaleMutationAgedMiddle AgedAdultAged, 80 and over

Stichwörter der Autor:innen

TP53colorectal adenocarcinomaimmunohistochemistrynext-generation sequencingthreshold

Substanzen

Tumor Suppressor Protein p53Biomarkers, TumorTP53 protein, human

Autor:innen und Institutionen

  • Department of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Department of Pathology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Department of Pathology, Fuzhou Second General Hospital, Fuzhou, China.

ORCID-Profile: Jingjing Wu

Förderung

  • National Natural Science Foundation of China
  • Fujian Provincial Health and Construction Commission, Young and middle-aged backbone personnel Training Project

Zitieren

APA

Wu, J., Yu, H., Huang, S., & Chen, X. (2026). A Retrospective Study of the Correlation Between Next-Generation Sequencing and Immunohistochemical Detection of TP53 in Colorectal Cancer. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338261420099

Vancouver

Wu J, Yu H, Huang S, Chen X. A Retrospective Study of the Correlation Between Next-Generation Sequencing and Immunohistochemical Detection of TP53 in Colorectal Cancer. Technology in Cancer Research & Treatment. 2026. doi:10.1177/15330338261420099

BibTeX
@article{Wu2026,
  author = {Wu, Jingjing and Yu, Haifeng and Huang, Shanshan and Chen, Xiangna},
  title = {A Retrospective Study of the Correlation Between Next-Generation Sequencing and Immunohistochemical Detection of TP53 in Colorectal Cancer},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  doi = {10.1177/15330338261420099}
}
Kostenlos starten →